INDRAPRASTHA MEDICAL CORP.LTD.
BSE: 532150
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 406.15+11.3% | 364.81-1.8% | 371.61-2.5% | 381.03+4.4% | 365.06+9.4% | 333.75+2.7% | 324.93-7.1% | 349.82 |
| Other Income | 8.42+14.9% | 7.33+2.5% | 7.15-3.0% | 7.37+6.8% | 6.90+8.7% | 6.35+23.8% | 5.13-15.2% | 6.05 |
| Total Income | 414.57+11.4% | 372.14-1.7% | 378.76-2.5% | 388.40+4.4% | 371.96+9.4% | 340.10+3.0% | 330.06-7.3% | 355.87 |
| EXPENSES | ||||||||
| Expenditure | 339.75+7.1% | 317.13-1.6% | 322.37+0.1% | 322.09+6.1% | 303.65+6.6% | 284.83-0.2% | 285.53-4.5% | 298.94 |
| Tax | 18.97+42.5% | 13.31-13.5% | 15.39-8.7% | 16.85+0.0% | 16.85+18.2% | 14.26+21.7% | 11.72-19.3% | 14.53 |
| PROFIT | ||||||||
| PBT | 74.82+36.0% | 55.01-2.4% | 56.39-15.0% | 66.31-2.9% | 68.31+23.6% | 55.27+24.1% | 44.53-21.8% | 56.93 |
| Net Profit | 55.85+33.9% | 41.70+1.7% | 41.00-17.1% | 49.46-3.9% | 51.46+25.5% | 41.01+25.0% | 32.81-22.6% | 42.40 |
| KEY METRICS | ||||||||
| OPM % | 19.65%+3.06pp | 16.59%-0.08pp | 16.67%-2.05pp | 18.72%-1.32pp | 20.04%+1.67pp | 18.37%+10.18pp | 8.19%-2.71pp | 10.90% |
| NPM % | 13.47%+2.26pp | 11.21%+0.39pp | 10.82%-1.91pp | 12.73%-1.10pp | 13.83%+1.77pp | 12.06%+2.12pp | 9.94%-1.97pp | 11.91% |
| EPS | 6.09+33.8% | 4.55+1.8% | 4.47-17.2% | 5.40-3.7% | 5.61+25.5% | 4.47+24.9% | 3.58-22.7% | 4.63 |
Corporate Events
Board MeetingINDRAMEDCO
202629Oct
Board Meeting
The meeting of the Board of Directors of the Company will be…
BSE Filing ↗ Board MeetingINDRAMEDCO
202624Sep
Board Meeting
The 38th Annual General Meeting (AGM) of the Company will be…
BSE Filing ↗ Board MeetingINDRAMEDCO
20266Aug
Board Meeting
A meeting of the Board of Directors of the Company will be h…
BSE Filing ↗ Board MeetingINDRAMEDCO
20261Jan
Board Meeting
Closure of Trading Window, Transaction involving securities
BSE Filing ↗ Board MeetingINDRAMEDCO
20251Apr
Board Meeting
Closure of trading window for dealing in shares
BSE Filing ↗ Board MeetingINDRAMEDCO
202417May
Board Meeting
consider and approve audited financial results for the quart…
BSE Filing ↗ Board MeetingINDRAMEDCO
20247Mar
Board Meeting
Consideration and Approval of Independent Director
BSE Filing ↗ Board MeetingINDRAMEDCO
20246Feb
Board Meeting
Consider and approve unaudited financial results for the qua…
BSE Filing ↗ Board MeetingINDRAMEDCO
20233Nov
Board Meeting
Consider and approve unaudited financial results
BSE Filing ↗